Risk-based decision making and ethical considerations in donor compensation for plasma-derived medicinal products.

dc.contributor.author	Grabowski, HG
dc.contributor.author	Skinner, MW
dc.contributor.author	Hoppe, PAH
dc.contributor.author	Manning, R
dc.contributor.author	Tachdjian, R
dc.contributor.author	Crone, JF
dc.contributor.author	Younger, SJ
dc.coverage.spatial	United States
dc.date.accessioned	2016-09-13T07:47:21Z
dc.date.issued	2016-09-07
dc.identifier	http://www.ncbi.nlm.nih.gov/pubmed/27600165
dc.identifier.eissn	1537-2995
dc.identifier.uri	https://hdl.handle.net/10161/12746
dc.language	eng
dc.publisher	Wiley: 12 months
dc.relation.ispartof	Transfusion
dc.relation.isversionof	10.1111/trf.13764
dc.title	Risk-based decision making and ethical considerations in donor compensation for plasma-derived medicinal products.
dc.type	Journal article
pubs.author-url	http://www.ncbi.nlm.nih.gov/pubmed/27600165
pubs.organisational-group	Duke
pubs.organisational-group	Economics
pubs.organisational-group	Trinity College of Arts & Sciences
pubs.publication-status	Published online

Files

Now showing 1 - 1 of 1